Search

everythinglearnresearchcommunity

for

Search:↓

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

Extracellular vesicles show promise in skin treatments but need more research and standardization.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The article concludes that hair restoration techniques must account for ongoing hair loss to ensure successful long-term results.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Thyroid disorders can cause skin issues in children, so early detection and screening are important.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

A stem cell-derived matrix speeds up healing of diabetic skin wounds.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Bariatric surgery can improve some skin issues but may worsen others due to nutritional deficiencies.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.

Skin diseases alter the skin's microbiome, and prebiotic treatments might help.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.